The licensing business model: turning intellectual property into revenue

A licensing business model earns revenue by allowing another organisation to use specified intellectual property under agreed conditions while ownership is retained. Payment may involve an upfront fee, recurring royalties or a combination. The commercial opportunity depends on more than possessing a patent, brand or software asset: the licensee must have the capabilities and incentive to use it successfully. Define the rights granted, the work each party must perform and how revenue will be measured before treating licensing as a repeatable income stream.

What can a business license?

WIPO’s guidance on assignment and licensing explains permission to use IP while retaining ownership, including patents, know-how, trademarks and copyright-protected works. Different rights can be combined in one commercial arrangement. A technology package might include patent rights, confidential manufacturing information and software; a branded service might combine a trademark with operating materials. The existence and scope of those rights need to be established before they are offered to a partner.

Create a practical inventory of what the licensee would receive. Distinguish registered rights from documentation, training, access to updates and ongoing support. A buyer may place much of the value on expertise that has never been written down. In that case, the business is selling a continuing transfer of capability as well as legal permission. Confirm that the company has the right to provide every component, including material created by employees, contractors or external suppliers.

Why would a capable partner pay for a licence?

The licensee needs a commercial advantage that justifies fees and implementation costs. That might be access to a recognised brand, a technology it could not readily develop or a shorter route to a marketable product. The licensor needs something too: manufacturing capacity, distribution, local service or specialist commercialisation. Describe both contributions. A royalty agreement will not create demand or production competence merely because it assigns responsibility for them.

Consider a hypothetical engineering SME with a proven industrial process but no overseas service network. A local partner may be able to integrate that process into equipment it already sells. Before granting broad rights, the SME should examine the partner’s technical staff, relevant customers, installation capability and capacity to support failures. A company with an impressive sales presentation may still lack the operational ability needed to turn licensed knowledge into reliable customer use.

How narrowly should permitted use be defined?

WIPO’s technology-transfer agreement guidance describes scope through matters such as territory, field of use and permitted activity. It also cautions that model agreements need adaptation to the circumstances. A licence to manufacture for a particular industrial application need not grant rights for every application worldwide. The commercial scope should follow what the partner can credibly develop and what the owner is prepared to commit.

Exclusive rights can help justify partner investment, but they also limit the owner’s alternatives. Connect the requested exclusivity to a credible development plan, required capabilities and observable progress. A geographically broad licence granted before the partner demonstrates demand can leave attractive markets inactive. A very narrow licence can make the partner’s investment unattractive. The right balance depends on the investment needed, alternative uses for that investment and the practical ability to monitor progress.

How do fees and royalties reflect the work involved?

An upfront fee can contribute towards access, onboarding or technology transfer. A recurring payment can align part of the licensor’s income with subsequent use or sales. A minimum payment may support committed access or exclusivity, but its affordability depends on the licensee’s realistic business plan. These mechanisms are negotiation choices, not standard returns that apply across industries. A rate cannot be assessed sensibly without the revenue base, deductions, support obligations and rights being exchanged.

In a hypothetical arrangement, a 4% royalty on £2 million of defined eligible sales produces £80,000 before the licensor’s costs and taxes. If exclusions reduce eligible sales to £1.5 million, the same stated rate produces £60,000. A £20,000 annual support burden would then leave £40,000 before other expenditure. This example shows why the calculation base and delivery obligations can matter as much as the headline percentage. It is not evidence of an appropriate market royalty.

What information is needed to trust royalty payments?

The agreement needs a workable way to connect the royalty calculation to records the licensee can actually produce. Define the relevant products, reporting period, treatment of returns and currency conversion, and the evidence supporting deductions. The WIPO GREEN licensing checklist raises royalty reporting, inspections and audit arrangements, including who pays for an audit. These are useful negotiation questions, not a substitute for a contract suited to the transaction.

Test a sample report before signing. A licensee whose systems cannot distinguish covered products from other products may be unable to provide reliable reports without additional work. Agree how discrepancies will be corrected and who can inspect sensitive information. Reporting should help both sides understand adoption as well as calculate fees. Falling shipments, rising returns or stalled implementation may call for support or revised expectations before they become a payment dispute.

What does the licensor still need to manage?

The owner may retain obligations for training, quality review, technical updates and confidential information. WIPO’s trade-secret guidance emphasises measures such as controlled access and confidentiality arrangements, with what is reasonable depending on circumstances. For a licensing operation, that makes the handover process important: decide who receives sensitive material, how access changes when staff leave and what can be shared with subcontractors. A confidentiality clause alone does not organise those activities.

Plan for contract expiry, failed commercialisation and a change of ownership at either party. Equipment, stock, customer support and access to updates may continue to matter after new sales stop. Formal requirements, competition rules, tax treatment and enforcement depend on the jurisdictions involved, so the final terms need appropriate local review. The commercial preparation remains useful: a clear rights package, capable partner and auditable revenue base make the legal work more concrete. The Arm licensing case illustrates one specialised implementation, while the European drug in-licensing guide shows why sector-specific commercial capabilities can dominate the outcome.